Dialysis Market by Type [Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, and Nocturnal Hemodialysis) and Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis)], Products & Services [Equipment (Dialysis Machines, Water Treatment Systems, and Others), Consumables (Dialyzers, Catheters, and Others), Drugs, and Services], and End User (In-center Dialysis and Home Dialysis): Global Opportunity Analysis and Industry Forecast, 2017-2023
Dialysis is usually carried out to remove toxins and excess of fluids formed in patient’s body due to inappropriate functioning of the kidney. This procedure is used to purify blood and treat end-stage renal disease (ESRD) and chronic renal failure. There are two types of dialysis: hemodialysis and peritoneal dialysis. Hemodialysis removes the waste products from the blood using an external filter whereas, during peritoneal dialysis, the toxins are removed using peritoneum, which acts as a natural semipermeable membrane. The global dialysis market was valued at $86 billion in 2016, and is estimated to reach $118 billion by 2023, registering a CAGR of 4.5% from 2017 to 2023.
The global dialysis market is segmented based on type, products & services, and geography. Based on type, it is bifurcated into hemodialysis and peritoneal dialysis. Hemodialysis is categorized into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Peritoneal dialysis is classified into continuous ambulatory peritoneal dialysis (CAPD), and automated peritoneal dialysis (APD). Based on products & services, the market is divided into instruments, consumables, drugs, and services. Devices are categorized into machines, dialyzers, water treatment systems, and others. Consumables are divided into dialysates, bloodlines, catheters, and transfer sets. Based on end user, it is bifurcated into in-center dialysis and home dialysis. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market growth is attributed to the increase in the number of diabetic and hypertension patients, increase in funding for development of new products, and rise in number of ESRD patients. Furthermore, dialysis is a preferred technique over kidney transplantation, which is expected to further boost the dialysis market growth. Moreover, the rise in geriatric population, increase in healthcare expenditure, and growth in disposable income are expected to fuel the market growth. However, lack of awareness about kidney diseases, product recall, and reduction in reimbursements for dialysis are expected to hinder the market growth.
KEY MARKET BENEFITS
By Type
The global dialysis market is segmented based on type, products & services, and geography. Based on type, it is bifurcated into hemodialysis and peritoneal dialysis. Hemodialysis is categorized into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Peritoneal dialysis is classified into continuous ambulatory peritoneal dialysis (CAPD), and automated peritoneal dialysis (APD). Based on products & services, the market is divided into instruments, consumables, drugs, and services. Devices are categorized into machines, dialyzers, water treatment systems, and others. Consumables are divided into dialysates, bloodlines, catheters, and transfer sets. Based on end user, it is bifurcated into in-center dialysis and home dialysis. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market growth is attributed to the increase in the number of diabetic and hypertension patients, increase in funding for development of new products, and rise in number of ESRD patients. Furthermore, dialysis is a preferred technique over kidney transplantation, which is expected to further boost the dialysis market growth. Moreover, the rise in geriatric population, increase in healthcare expenditure, and growth in disposable income are expected to fuel the market growth. However, lack of awareness about kidney diseases, product recall, and reduction in reimbursements for dialysis are expected to hinder the market growth.
KEY MARKET BENEFITS
- This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
- The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
- The global market is comprehensively analyzed with respect to type, products & services, end user, and geography.
- In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
- The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
- Fresenius Medical Care AG & Co. KGaA
- Baxter International, Inc.
- DaVita Inc.
- Nipro Corporation
- B. Braun Avitum AG
- Diaverum Deutschland GmbH
- Nikkiso Co. Ltd.
- NxStage Medical, Inc.
- Asahi Kasei Corporation
- Medicators, Inc.
By Type
- Hemodialysis
- Conventional Hemodialysis
- Short Daily Hemodialysis
- Nocturnal Hemodialysis
- Peritoneal Dialysis
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)
- Equipment
- Dialysis Machines
- Water Treatment Systems
- Others
- Consumables
- Dialyzers
- Catheters
- Others
- Drugs
- Services
- In-center Dialysis
- Home Dialysis
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Republic of South Africa
- Saudi Arabia
- Rest of LAMEA
- Atlantic Biomedical P. Ltd.
- JMS Co., Ltd.
- Toray Medical Co., Ltd.,
- Rockwell Medical Technologies
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Increase in funding for development of new products
3.5.1.2. Increase in number of ESRD patients
3.5.1.3. Rise in incidence of diabetes and hypertension
3.5.1.4. Preferred technique over kidney transplantation
3.5.2. Restraints
3.5.2.1. Reduction in reimbursements for dialysis
3.5.2.2. Risks and complications associated with dialysis
3.5.2.3. Product recall
3.5.3. Opportunities
3.5.3.1. Technological Advancements Leading to Better Adoption
3.5.3.2. Rise in demand for home peritoneal dialysis treatment
3.5.3.3. Untapped Markets in Developing Economies
CHAPTER 4 DIALYSIS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. HEMODIALYSIS
4.2.1. Market size and forecast
4.2.2. Conventional hemodialysis
4.2.2.1. Market size and forecast
4.2.3. Short daily hemodialysis
4.2.3.1. Market size and forecast
4.2.4. Nocturnal hemodialysis
4.2.4.1. Market size and forecast
4.3. PERITONEAL DIALYSIS
4.3.1. Market size and forecast
4.3.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
4.3.2.1. Market size and forecast
4.3.3. Automated Peritoneal Dialysis (APD)
4.3.3.1. Market size and forecast
CHAPTER 5 DIALYSIS MARKET, BY PRODUCTS & SERVICES
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. EQUIPMENT
5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. Dialysis Machines
5.2.4.1. Market size and forecast
5.2.5. Water Treatment Systems
5.2.5.1. Market size and forecast
5.2.6. Others dialysis equipment
5.2.6.1. Market size and forecast
5.3. CONSUMABLES
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Dialyzers
5.3.4.1. Market size and forecast
5.3.5. Catheters
5.3.5.1. Market size and forecast
5.3.6. Other dialysis consumables
5.3.6.1. Market size and forecast
5.4. DIALYSIS DRUGS
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
5.5. SERVICES
5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast
CHAPTER 6 DIALYSIS MARKET, BY END USERS
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. IN-CENTER DIALYSIS
6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast
6.3. HOME DIALYSIS
6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast
CHAPTER 7 DIALYSIS MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Mexico market size and forecast
7.2.3.3. Canada market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. UK market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. Germany market size and forecast
7.3.3.4. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. India market size and forecast
7.4.3.2. Japan market size and forecast
7.4.3.3. China market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. South Africa market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1. FRESENIUS MEDICAL CARE AG & CO. KGAA
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. BAXTER INTERNATIONAL, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.3. DAVITA INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. NIPRO CORPORATION
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.5. B. BRAUN AVITUM AG
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments
8.6. DIAVERUM DEUTSCHLAND GMBH.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.7. NIKKISO CO. LTD.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments
8.8. NXSTAGE MEDICAL, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.9. MEDICATORS, INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.10. ASAHI KASEI CORPORATION
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Increase in funding for development of new products
3.5.1.2. Increase in number of ESRD patients
3.5.1.3. Rise in incidence of diabetes and hypertension
3.5.1.4. Preferred technique over kidney transplantation
3.5.2. Restraints
3.5.2.1. Reduction in reimbursements for dialysis
3.5.2.2. Risks and complications associated with dialysis
3.5.2.3. Product recall
3.5.3. Opportunities
3.5.3.1. Technological Advancements Leading to Better Adoption
3.5.3.2. Rise in demand for home peritoneal dialysis treatment
3.5.3.3. Untapped Markets in Developing Economies
CHAPTER 4 DIALYSIS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. HEMODIALYSIS
4.2.1. Market size and forecast
4.2.2. Conventional hemodialysis
4.2.2.1. Market size and forecast
4.2.3. Short daily hemodialysis
4.2.3.1. Market size and forecast
4.2.4. Nocturnal hemodialysis
4.2.4.1. Market size and forecast
4.3. PERITONEAL DIALYSIS
4.3.1. Market size and forecast
4.3.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
4.3.2.1. Market size and forecast
4.3.3. Automated Peritoneal Dialysis (APD)
4.3.3.1. Market size and forecast
CHAPTER 5 DIALYSIS MARKET, BY PRODUCTS & SERVICES
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. EQUIPMENT
5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. Dialysis Machines
5.2.4.1. Market size and forecast
5.2.5. Water Treatment Systems
5.2.5.1. Market size and forecast
5.2.6. Others dialysis equipment
5.2.6.1. Market size and forecast
5.3. CONSUMABLES
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Dialyzers
5.3.4.1. Market size and forecast
5.3.5. Catheters
5.3.5.1. Market size and forecast
5.3.6. Other dialysis consumables
5.3.6.1. Market size and forecast
5.4. DIALYSIS DRUGS
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
5.5. SERVICES
5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast
CHAPTER 6 DIALYSIS MARKET, BY END USERS
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. IN-CENTER DIALYSIS
6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast
6.3. HOME DIALYSIS
6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast
CHAPTER 7 DIALYSIS MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Mexico market size and forecast
7.2.3.3. Canada market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. UK market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. Germany market size and forecast
7.3.3.4. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. India market size and forecast
7.4.3.2. Japan market size and forecast
7.4.3.3. China market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. South Africa market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1. FRESENIUS MEDICAL CARE AG & CO. KGAA
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. BAXTER INTERNATIONAL, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.3. DAVITA INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. NIPRO CORPORATION
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.5. B. BRAUN AVITUM AG
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments
8.6. DIAVERUM DEUTSCHLAND GMBH.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.7. NIKKISO CO. LTD.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments
8.8. NXSTAGE MEDICAL, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.9. MEDICATORS, INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.10. ASAHI KASEI CORPORATION
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL HEMODIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. GLOBAL HEMODIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL CONVENTIONAL HEMODIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL SHORT DAILY HEMODIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL NOCTURNAL HEMODIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL PERITONEAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 8. GLOBAL PERITONEAL DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL CONTINUOUS AMBULATORY PERITONEAL DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL AUTOMATED PERITONEAL DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL DIALYSIS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 12. GLOBAL EQUIPMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 13. GLOBAL EQUIPMENT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL MACHINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL WATER TREATMENT SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL OTHERS DIALYSIS EQUIPMENT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. GLOBAL CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 18. GLOBAL CONSUMABLES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. GLOBAL DIALYZERS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL CATHETERS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL OTHER DIALYSIS CONSUMABLES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. GLOBAL DIALYSIS DRUGS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL SERVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 24. GLOBAL DIALYSIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 25. GLOBAL IN-CENTER DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 26. GLOBAL HOME DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 27. DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 28. NORTH AMERICA DIALYSIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA HEMODIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA PERITONEAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA DIALYSIS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA EQUIPMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 35. NORTH AMERICA DIALYSIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. EUROPE DIALYSIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 37. EUROPE DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 38. EUROPE HEMODIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 39. EUROPE PERITONEAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 40. EUROPE DIALYSIS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 41. EUROPE EQUIPMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 42. EUROPE CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 43. EUROPE DIALYSIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 44. ASIA-PACIFIC DIALYSIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 48. ASIA-PACIFIC DIALYSIS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 49. ASIA-PACIFIC EQUIPMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 50. ASIA-PACIFIC CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 51. ASIA-PACIFIC DIALYSIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 52. LAMEA DIALYSIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 53. LAMEA DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 54. LAMEA HEMODIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 55. LAMEA PERITONEAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 56. LAMEA DIALYSIS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 57. LAMEA EQUIPMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 58. LAMEA CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 59. LAMEA DIALYSIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 60. FRESENIUS: COMPANY SNAPSHOT
TABLE 61. FRESENIUS: OPERATING SEGMENTS
TABLE 62. BAXTER: COMPANY SNAPSHOT
TABLE 63. BAXTER: OPERATING SEGMENTS
TABLE 64. DAVITA: COMPANY SNAPSHOT
TABLE 65. DAVITA: OPERATING SEGMENTS
TABLE 66. NIPRO: COMPANY SNAPSHOT
TABLE 67. NIPRO: OPERATING SEGMENTS
TABLE 68. B. BRAUN: COMPANY SNAPSHOT
TABLE 69. B. BRAUN: OPERATING SEGMENTS
TABLE 70. DIAVERUM: COMPANY SNAPSHOT
TABLE 71. DIAVERUM: OPERATING SEGMENTS
TABLE 72. NIKKISO: COMPANY SNAPSHOT
TABLE 73. NIKKISO: OPERATING SEGMENTS
TABLE 74. NXSTAGE: COMPANY SNAPSHOT
TABLE 75. NXSTAGE: OPERATING SEGMENTS
TABLE 76. MEDICATORS: COMPANY SNAPSHOT
TABLE 77. MEDICATORS: OPERATING SEGMENTS
TABLE 78. GAMBRO: COMPANY SNAPSHOT
TABLE 79. ASAHI: OPERATING SEGMENTS
TABLE 1. GLOBAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL HEMODIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. GLOBAL HEMODIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL CONVENTIONAL HEMODIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL SHORT DAILY HEMODIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL NOCTURNAL HEMODIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL PERITONEAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 8. GLOBAL PERITONEAL DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL CONTINUOUS AMBULATORY PERITONEAL DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL AUTOMATED PERITONEAL DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL DIALYSIS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 12. GLOBAL EQUIPMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 13. GLOBAL EQUIPMENT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL MACHINES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL WATER TREATMENT SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL OTHERS DIALYSIS EQUIPMENT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. GLOBAL CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 18. GLOBAL CONSUMABLES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. GLOBAL DIALYZERS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL CATHETERS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL OTHER DIALYSIS CONSUMABLES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. GLOBAL DIALYSIS DRUGS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL SERVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 24. GLOBAL DIALYSIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 25. GLOBAL IN-CENTER DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 26. GLOBAL HOME DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 27. DIALYSIS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 28. NORTH AMERICA DIALYSIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA HEMODIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA PERITONEAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA DIALYSIS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA EQUIPMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 35. NORTH AMERICA DIALYSIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. EUROPE DIALYSIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 37. EUROPE DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 38. EUROPE HEMODIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 39. EUROPE PERITONEAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 40. EUROPE DIALYSIS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 41. EUROPE EQUIPMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 42. EUROPE CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 43. EUROPE DIALYSIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 44. ASIA-PACIFIC DIALYSIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 48. ASIA-PACIFIC DIALYSIS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 49. ASIA-PACIFIC EQUIPMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 50. ASIA-PACIFIC CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 51. ASIA-PACIFIC DIALYSIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 52. LAMEA DIALYSIS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 53. LAMEA DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 54. LAMEA HEMODIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 55. LAMEA PERITONEAL DIALYSIS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 56. LAMEA DIALYSIS MARKET, BY PRODUCTS & SERVICES, 2016-2023 ($MILLION)
TABLE 57. LAMEA EQUIPMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 58. LAMEA CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 59. LAMEA DIALYSIS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 60. FRESENIUS: COMPANY SNAPSHOT
TABLE 61. FRESENIUS: OPERATING SEGMENTS
TABLE 62. BAXTER: COMPANY SNAPSHOT
TABLE 63. BAXTER: OPERATING SEGMENTS
TABLE 64. DAVITA: COMPANY SNAPSHOT
TABLE 65. DAVITA: OPERATING SEGMENTS
TABLE 66. NIPRO: COMPANY SNAPSHOT
TABLE 67. NIPRO: OPERATING SEGMENTS
TABLE 68. B. BRAUN: COMPANY SNAPSHOT
TABLE 69. B. BRAUN: OPERATING SEGMENTS
TABLE 70. DIAVERUM: COMPANY SNAPSHOT
TABLE 71. DIAVERUM: OPERATING SEGMENTS
TABLE 72. NIKKISO: COMPANY SNAPSHOT
TABLE 73. NIKKISO: OPERATING SEGMENTS
TABLE 74. NXSTAGE: COMPANY SNAPSHOT
TABLE 75. NXSTAGE: OPERATING SEGMENTS
TABLE 76. MEDICATORS: COMPANY SNAPSHOT
TABLE 77. MEDICATORS: OPERATING SEGMENTS
TABLE 78. GAMBRO: COMPANY SNAPSHOT
TABLE 79. ASAHI: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 1. SEGMENTATION OF GLOBAL DIALYSIS MARKET
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL DIALYSIS MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF NEW ENTRANTS
FIGURE 9. THREAT OF SUBSTITUTION
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. RESTRAINTS AND DRIVERS: GLOBAL DIALYSIS MARKET
FIGURE 12. GLOBAL DIALYSIS MARKET: SEGMENTATION BY TYPE
FIGURE 13. GLOBAL DIALYSIS MARKET: SEGMENTATION BY PRODUCTS & SERVICES
FIGURE 14. GLOBAL DIALYSIS MARKET: SEGMENTATION BY END USERS
FIGURE 15. U.S. DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 16. MEXICO DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 17. CANADA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 18. UK DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 19. FRANCE DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 20. GERMANY DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 22. INDIA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 23. JAPAN DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 24. CHINA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 25. REST OF ASIA-PACIFIC DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 26. BRAZIL DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 27. SOUTH AFRICA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 28. SAUDI ARABIA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 29. REST OF LAMEA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 30. FRESENIUS: NET SALES, 2013-2016 ($MILLION)
FIGURE 31. FRESENIUS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 32. FRESENIUS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 33. BAXTER: NET SALES, 2013-2016 ($MILLION)
FIGURE 34. BAXTER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 35. BAXTER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 36. DAVITA: NET SALES, 2013-2016 ($MILLION)
FIGURE 37. DAVITA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 38. DAVITA: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 39. NIPRO: NET SALES, 2013-2016 ($MILLION)
FIGURE 40. NIPRO: REVENUE BY SEGMENT, 2016 (%)
FIGURE 41. NIPRO: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 42. B. BRAUN: NET SALES, 2013-2016 ($MILLION)
FIGURE 43. B. BRAUN: REVENUE BY SEGMENT, 2016 (%)
FIGURE 44. B. BRAUN: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 45. DIAVERUM: NET SALES, 2013-2016 ($MILLION)
FIGURE 46. DIAVERUM: REVENUE BY SEGMENT, 2016 (%)
FIGURE 47. DIAVERUM: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 48. NIKKISO: NET SALES, 2013-2016 ($MILLION)
FIGURE 49. NIKKISO: REVENUE BY SEGMENT, 2016 (%)
FIGURE 50. NIKKISO: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 51. NXSTAGE: NET SALES, 2013-2016 ($MILLION)
FIGURE 52. NXSTAGE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 53. NXSTAGE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 54. MEDICATORS: NET SALES, 2013-2016 ($MILLION)
FIGURE 55. MEDICATORS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 56. MEDICATORS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 57. ASAHI: NET SALES, 2013-2016 ($MILLION)
FIGURE 58. ASAHI: REVENUE BY SEGMENT, 2016 (%)
FIGURE 59. ASAHI: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 1. SEGMENTATION OF GLOBAL DIALYSIS MARKET
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL DIALYSIS MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF NEW ENTRANTS
FIGURE 9. THREAT OF SUBSTITUTION
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. RESTRAINTS AND DRIVERS: GLOBAL DIALYSIS MARKET
FIGURE 12. GLOBAL DIALYSIS MARKET: SEGMENTATION BY TYPE
FIGURE 13. GLOBAL DIALYSIS MARKET: SEGMENTATION BY PRODUCTS & SERVICES
FIGURE 14. GLOBAL DIALYSIS MARKET: SEGMENTATION BY END USERS
FIGURE 15. U.S. DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 16. MEXICO DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 17. CANADA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 18. UK DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 19. FRANCE DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 20. GERMANY DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 22. INDIA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 23. JAPAN DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 24. CHINA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 25. REST OF ASIA-PACIFIC DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 26. BRAZIL DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 27. SOUTH AFRICA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 28. SAUDI ARABIA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 29. REST OF LAMEA DIALYSIS MARKET, 2016-2023 ($MILLION)
FIGURE 30. FRESENIUS: NET SALES, 2013-2016 ($MILLION)
FIGURE 31. FRESENIUS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 32. FRESENIUS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 33. BAXTER: NET SALES, 2013-2016 ($MILLION)
FIGURE 34. BAXTER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 35. BAXTER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 36. DAVITA: NET SALES, 2013-2016 ($MILLION)
FIGURE 37. DAVITA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 38. DAVITA: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 39. NIPRO: NET SALES, 2013-2016 ($MILLION)
FIGURE 40. NIPRO: REVENUE BY SEGMENT, 2016 (%)
FIGURE 41. NIPRO: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 42. B. BRAUN: NET SALES, 2013-2016 ($MILLION)
FIGURE 43. B. BRAUN: REVENUE BY SEGMENT, 2016 (%)
FIGURE 44. B. BRAUN: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 45. DIAVERUM: NET SALES, 2013-2016 ($MILLION)
FIGURE 46. DIAVERUM: REVENUE BY SEGMENT, 2016 (%)
FIGURE 47. DIAVERUM: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 48. NIKKISO: NET SALES, 2013-2016 ($MILLION)
FIGURE 49. NIKKISO: REVENUE BY SEGMENT, 2016 (%)
FIGURE 50. NIKKISO: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 51. NXSTAGE: NET SALES, 2013-2016 ($MILLION)
FIGURE 52. NXSTAGE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 53. NXSTAGE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 54. MEDICATORS: NET SALES, 2013-2016 ($MILLION)
FIGURE 55. MEDICATORS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 56. MEDICATORS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 57. ASAHI: NET SALES, 2013-2016 ($MILLION)
FIGURE 58. ASAHI: REVENUE BY SEGMENT, 2016 (%)
FIGURE 59. ASAHI: REVENUE BY GEOGRAPHY, 2016 (%)
